Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Vertex Pharmaceuticals (NasdaqGS:VRTX) entered an agreement with WuXi Biologics to ...

Christopher Young: Welcome everyone and thank you for joining us. It's great to join you on my first earnings conference call as President and CEO of Vertex. Our financial results for the fourth ...

What happened the last time Vertex reported earnings? The company reported third-quarter earnings on Nov. 3. Revenue was up 11% year over year to $3.08 billion. However, earnings per share (EPS) rose ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Vertex has delivered earnings growth over the past decade thanks to its leadership in cystic fibrosis treatment. In recent years, the company has launched products in other treatment areas too. On top ...

Wagner guided, "We expect full year 2026 total company revenue to be in the range of $12.95 billion to $13.1 billion, representing 8% to 9% growth versus the prior year. This outlook anticipates ...

The Isky story is in many ways the story of the American century. Edward “Isky” Iskenderian was born before the Great Depression, and his parents lost their vineyard in the Central Valley of ...

As one of the most anticipated tentpole features of the year, excitement for Avengers: Doomsday couldn't be much higher. With a stacked cast, some of whom are returning to the Marvel Cinematic ...

In hot rodding circles, we’re often told to respect our elders. But what happens when your elders have elders to respect? The complete lineage of American hot rodding stretches back the better part of ...